The Technical Analyst
Select Language :
Vir Biotechnology Inc [VIR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Vir Biotechnology Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Vir Biotechnology Inc is listed at the  Exchange

0.30% $10.13

America/New_York / 28 mar 2024 @ 16:00


Vir Biotechnology Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 1 367.87 mill
EPS: -4.59
P/E: -2.21
Earnings Date: May 02, 2024
SharesOutstanding: 135.03 mill
Avg Daily Volume: 1.100 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.21 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.38x
Company: PE -2.21 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 9.58 - 10.68

( +/- 5.43%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-27 Lee Sung Sell 6 008 Common Stock
2024-02-22 Hanly Ann M. Buy 32 500 Common Stock
2024-02-22 Hanly Ann M. Sell 12 296 Common Stock
2024-02-22 Hanly Ann M. Buy 65 000 Stock Option (Right to Buy)
2024-02-22 De Backer Marianne Buy 175 000 Common Stock
INSIDER POWER
-9.64
Last 98 transactions
Buy: 8 177 990 | Sell: 9 707 510

Forecast: 16:00 - $10.13

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $10.13
Forecast 2: 16:00 - $10.13
Forecast 3: 16:00 - $10.13
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $10.13 (0.30% )
Volume 0.681 mill
Avg. Vol. 1.100 mill
% of Avg. Vol 61.90 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Vir Biotechnology Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Vir Biotechnology Inc

RSI

Intraday RSI14 chart for Vir Biotechnology Inc

Last 10 Buy & Sell Signals For VIR

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$9.17N/AActive
Profile picture for
            Vir Biotechnology Inc

VIR

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Last 10 Buy Signals

Date Signal @
KUBUSDMar 29 - 05:132.70
EOSUSDMar 29 - 05:15$1.083
HATUSDMar 29 - 05:023 532.25
FETUSDMar 29 - 04:58$3.24
SOCKSUSDMar 29 - 04:5335 606
OSHIUSDMar 29 - 04:4981.91
HBTCUSDMar 29 - 04:3834 558
DESOUSDMar 29 - 04:3931.41
ARUSDMar 29 - 04:28$41.19
KCSUSDMar 29 - 04:24$11.87

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.